For people normally considered decades away from dementia:
– Ages 35–49 taking gabapentin had more than double the risk of dementia.
– Adults 50–64 saw similarly elevated risks.
– Only those 18–34 showed no increased risk.
Researchers published their results in Regional Anesthesia & Pain Medicine said: “Our results support the need for close monitoring of adult patients prescribed gabapentin to assess for potential cognitive decline.”
